The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures
Muscle & Nerve2013Vol. 48(1), pp. 55–67
Citations Over TimeTop 10% of 2013 papers
Erik Henricson, Richard T. Abresch, Avital Cnaan, Fengming Hu, Tina Duong, Adrienne Arrieta, Jay J. Han, Diana M. Escolar, Julaine Florence, Paula R. Clemens, Eric P. Hoffman, Craig M. McDonald, the CINRG Investigators
Abstract
In DMD, long-term use of GCs showed reduced strength loss and preserved functional capabilities and PFTs compared with previous natural history studies performed prior to the widespread use of GC therapy.
Related Papers
- → Use of Advanced Heart Failure Therapies in Duchenne Muscular Dystrophy(2018)1 cited
- → A New Milestone from Cibyra(2023)1 cited
- [Delayed diagnosis of Duchenne muscular dystrophy in Chile].(1999)
- → Non-invasive tension-time-index and ventilator use in Duchenne muscular dystrophy(2008)
- → IEEE milestone for Germany: the EMC society is "instrumental" in making it happen!(2016)